Deeya Lifescience Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 12 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Deeya Lifescience
Deeya Lifescience Private Limited (DLPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 May 2012 and has a history of 12 years and eight months. Its registered office is in Mumbai, Maharashtra, India.
The Corporate was formerly known as Brucke Lifescience Private Limited. The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Dokania, Meenadevi Kejriwal, Devendra Kejriwal, and One other member serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2012PTC230619
-
Company No.
230619
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 May 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Deeya Lifescience?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Dokania
|
Director | 14-Oct-2020 | Current |
|
Meenadevi Kejriwal
|
Director | 03-Sep-2022 | Current |
|
Devendra Kejriwal
|
Director | 04-May-2012 | Current |
|
Payal Kejriwal
|
Director | 03-Sep-2022 | Current |
Financial Performance of Deeya Lifescience.
Deeya Lifescience Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Deeya Lifescience?
In 2017, Deeya Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bruck Pharma LimitedMeenadevi Kejriwal is a mutual person
-
Ganilk Private LimitedDevendra Kejriwal is a mutual person
-
Kamdar Agriculture Private LimitedRajesh Dokania is a mutual person
-
Primax Commerce Pvt Ltd
Rajesh Dokania and Meenadevi Kejriwal are mutual person
-
Mashaal Insurance Advisors Limited
Rajesh Dokania and Meenadevi Kejriwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Deeya Lifescience?
Unlock and access historical data on people associated with Deeya Lifescience, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Deeya Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deeya Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
